multiple sclerosis

Should Biogen Be Afraid of This Upstart?
Investopedia
Mon, 04/13/15 - 10:02 pm
Biogen
Receptos
MS
multiple sclerosis
ozanimod
Tecfidera
Teva takes another swing at generic Copaxone with new FDA petition
Fierce Pharma
Thu, 04/2/15 - 01:58 pm
Teva
Copaxone
FDA
generics
multiple sclerosis
Merck KGaA pitches in an extra $3M to support Opexa's PhIIb for MS
Fierce Biotech
Mon, 03/9/15 - 12:01 pm
Merck KGaA
Opexa
Serono
MS
multiple sclerosis
Merck's Rebif held its own in last year's MS market shakeup. What about 2015?
Fierce Pharma
Tue, 03/3/15 - 01:27 pm
Rebif
MS
multiple sclerosis
Merck KGaA
Merck KGaA carves into MS R&D after a string of setbacks
Fierce Biotech
Mon, 02/23/15 - 10:16 am
Merck KGaA
MS
multiple sclerosis
R&D
Alkermes says its more tolerable Tecfidera rival is ready for pivotal challenge
Fierce Biotech
Mon, 02/9/15 - 05:59 pm
Alkermes
ALKS 8700
MS
multiple sclerosis
Biogen Idec
Tecfidera
Teva Pharmaceutical's Strategy Proves to be Brilliant
Motley Fool
Fri, 02/6/15 - 05:51 pm
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
Acorda cautiously steps forward with a drug to spur remyelination in MS
Fierce Biotech
Mon, 02/2/15 - 07:52 am
Acorda Therapeutics
MS
multiple sclerosis
remylination
rHIgM22
Google, Biogen Work Together on Multiple Sclerosis Research
Bloomberg
Wed, 01/28/15 - 08:28 am
Google
Biogen Idec
MS
multiple sclerosis
U.S. Supreme Court rules for Teva in over multiple sclerosis drug patent
Yahoo/Reuters
Tue, 01/20/15 - 11:34 am
Teva Pharmaceuticals
Supreme Court
Copaxone
patents
MS
multiple sclerosis
Receptos Shopping For A Partner With Strong Data In Hand
Seeking Alpha
Thu, 01/15/15 - 12:05 pm
Receptos
AbbVie
Biogen Idec
JNJ
Novartis
RPC1063
ulcerative colitis
multiple sclerosis
Biogen issues early data on potential game-changing MS drug. Investors shrug.
Bizjournals.com
Thu, 01/8/15 - 02:48 pm
Biogen Idec
MS
multiple sclerosis
anti-LINGO-1
Gardasil HPV Vaccine Not Linked To Multiple Sclerosis Or Related Diseases
Forbes
Tue, 01/6/15 - 11:35 am
Gardasil
vaccines
HPV
multiple sclerosis
The bright side to Sanofi's Lemtrada delay? Its support-to-sell marketing plan
Fierce Pharma Marketing
Wed, 12/24/14 - 09:31 am
Sanofi
Lemtrada
Genzyme
MS
multiple sclerosis
Biogen Straps Fitbits Onto MS Patients' Wrists
Bloomberg/Businessweek
Wed, 12/24/14 - 08:52 am
Biogen Idec
Fitbit
multiple sclerosis
MS
First MS Patients in the U.S. Receive Genzyme’s Lemtrada Following FDA Approval
Yahoo
Wed, 12/3/14 - 08:13 am
Genzyme
MS
multiple sclerosis
Lemtrada
Novartis’s Gilenya Fails to Help Hard-to-Treat Form of MS
Bloomberg
Mon, 12/1/14 - 09:59 am
Novartis
Gilenya
MS
multiple sclerosis
Sanofi tags newly OK'd MS drug Lemtrada at $158K, ready to tout head-to-head Rebif data
Fierce Pharma Marketing
Tue, 11/18/14 - 11:01 am
Sanofi
Lemtrada
MS
multiple sclerosis
Genzyme’s Lemtrada Approved by the FDA
Yahoo/Businesswire
Sat, 11/15/14 - 09:34 am
Genzyme
Lemtrada
multiple sclerosis
MS
TEVA: Copaxone Patent Expiry Worries Are Overblown
Seeking Alpha
Wed, 11/12/14 - 08:44 am
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
patents

Pages